Torezolid phosphate: Phase III started

Trius began a double-blind, active-controlled Phase III trial to evaluate 200 mg oral torezolid given once daily for 6 days vs. 600 mg oral Zyvox linezolid given twice daily for 10 days. Trius has an ...